Advancing Precision Diagnostics in Nuclear Medicine
Scintagen develops next-generation radiopharmaceuticals that bring advanced molecular imaging within reach of more care settings — for patients worldwide.
Innovation with Clinical Purpose
Scintagen is a U.S.-based radiopharmaceutical company built on global science. Headquartered in Florida, we combine American regulatory and commercial expertise with international scientific collaboration to bring advanced molecular imaging to more patients, in more places.
Precision
Molecular-level targeting designed to deliver clearer answers and greater diagnostic confidence.
Accessibility
Programs engineered to fit within existing clinical infrastructure and reach broader patient populations.
Innovation
A translational approach that pairs rigorous science with a clear-eyed view of real-world clinical use.
A Focused Scientific Approach
We are building a portfolio of molecular imaging agents guided by one question: what will actually change practice for patients and the clinicians who care for them?
Molecular Imaging Agents
We focus on radiolabeled probes designed to illuminate biology with clarity — engineered for signal, specificity, and clean pharmacokinetics.
Built for Existing Infrastructure
Our programs are shaped by the realities of clinical workflows and the imaging equipment already installed in the field, not around them.
Scalable by Design
Chemistry and supply strategies chosen with breadth in mind — so what works in a leading center can also work everywhere else.
Where We're Headed
Our lead program is advancing steadily through development toward the clinic. As it matures, we will share more — thoughtfully, and when the science warrants.
Let's Start a Conversation
We welcome inquiries from partners, investors, and collaborators who share our commitment to advancing molecular imaging.
info@scintagen.com